Cite
Adherence and future discontinuation of tyrosine kinase inhibitors in chronic phase chronic myeloid leukemia. A patient-based survey on 1133 patients
MLA
Luigiana Luciano, et al. Adherence and Future Discontinuation of Tyrosine Kinase Inhibitors in Chronic Phase Chronic Myeloid Leukemia. A Patient-Based Survey on 1133 Patients. Jan. 2015. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....8de97091f48cd9a6c1aa7b7433044313&authtype=sso&custid=ns315887.
APA
Luigiana Luciano, Michele Cedrone, Daniele Vallisa, Francesco Cavazzini, Anna Guella, Massimo Breccia, P. Danise, Emilio Usala, Monica Crugnola, Paolo Avanzini, Fabio Stagno, Diamante Turri, Monica Bocchia, Patrizia Pregno, Gianni Binotto, Mario Tiribelli, Angelo Michele Carella, Ida Nardiello, E Orlandi, … Antonella Gozzini. (2015). Adherence and future discontinuation of tyrosine kinase inhibitors in chronic phase chronic myeloid leukemia. A patient-based survey on 1133 patients.
Chicago
Luigiana Luciano, Michele Cedrone, Daniele Vallisa, Francesco Cavazzini, Anna Guella, Massimo Breccia, P. Danise, et al. 2015. “Adherence and Future Discontinuation of Tyrosine Kinase Inhibitors in Chronic Phase Chronic Myeloid Leukemia. A Patient-Based Survey on 1133 Patients,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....8de97091f48cd9a6c1aa7b7433044313&authtype=sso&custid=ns315887.